List of Tables
Table 1. Global Hemophilia A Drug Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Hemophilia A Drug Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Hemophilia A Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Hemophilia A Drug Covered in This Study
Table 5. Global Hemophilia A Drug Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Hemophilia A Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Hemophilia A Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Hemophilia A Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Hemophilia A Drug Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Hemophilia A Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Hemophilia A Drug Product Type
Table 12. Global Hemophilia A Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hemophilia A Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia A Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hemophilia A Drug Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Hemophilia A Drug Sales Market Share by Region (2016-2021)
Table 17. Global Hemophilia A Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Hemophilia A Drug Sales Market Share by Country (2016-2021)
Table 20. North America Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Hemophilia A Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Hemophilia A Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Hemophilia A Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Hemophilia A Drug Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Hemophilia A Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Hemophilia A Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Hemophilia A Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Hemophilia A Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Hemophilia A Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Hemophilia A Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Hemophilia A Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Hemophilia A Drug Sales (K Pcs) by Type (2016-2021)
Table 39. Global Hemophilia A Drug Sales Market Share by Type (2016-2021)
Table 40. Global Hemophilia A Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Hemophilia A Drug Revenue Share by Type (2016-2021)
Table 42. Global Hemophilia A Drug Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Hemophilia A Drug Sales (K Pcs) by Application (2016-2021)
Table 44. Global Hemophilia A Drug Sales Market Share by Application (2016-2021)
Table 45. Global Hemophilia A Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Hemophilia A Drug Revenue Share by Application (2016-2021)
Table 47. Global Hemophilia A Drug Price (USD/Pcs) by Application (2016-2021)
Table 48. Bayer AG Corporation Information
Table 49. Bayer AG Description and Business Overview
Table 50. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Bayer AG Hemophilia A Drug Product
Table 52. Bayer AG Recent Developments/Updates
Table 53. BioMarin Pharmaceutical Inc Corporation Information
Table 54. BioMarin Pharmaceutical Inc Description and Business Overview
Table 55. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. BioMarin Pharmaceutical Inc Hemophilia A Drug Product
Table 57. BioMarin Pharmaceutical Inc Recent Developments/Updates
Table 58. Bioverativ Inc Corporation Information
Table 59. Bioverativ Inc Description and Business Overview
Table 60. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Bioverativ Inc Hemophilia A Drug Product
Table 62. Bioverativ Inc Recent Developments/Updates
Table 63. Catalyst Biosciences Inc Corporation Information
Table 64. Catalyst Biosciences Inc Description and Business Overview
Table 65. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Catalyst Biosciences Inc Hemophilia A Drug Product
Table 67. Catalyst Biosciences Inc Recent Developments/Updates
Table 68. Chugai Pharmaceutical Co Ltd Corporation Information
Table 69. Chugai Pharmaceutical Co Ltd Description and Business Overview
Table 70. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product
Table 72. Chugai Pharmaceutical Co Ltd Recent Developments/Updates
Table 73. CSL Ltd Corporation Information
Table 74. CSL Ltd Description and Business Overview
Table 75. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. CSL Ltd Hemophilia A Drug Product
Table 77. CSL Ltd Recent Developments/Updates
Table 78. DBV Technologies SA Corporation Information
Table 79. DBV Technologies SA Description and Business Overview
Table 80. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. DBV Technologies SA Hemophilia A Drug Product
Table 82. DBV Technologies SA Recent Developments/Updates
Table 83. Dimension Therapeutics Inc Corporation Information
Table 84. Dimension Therapeutics Inc Description and Business Overview
Table 85. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Dimension Therapeutics Inc Hemophilia A Drug Product
Table 87. Dimension Therapeutics Inc Recent Developments/Updates
Table 88. EpiVax Inc Corporation Information
Table 89. EpiVax Inc Description and Business Overview
Table 90. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. EpiVax Inc Hemophilia A Drug Product
Table 92. EpiVax Inc Recent Developments/Updates
Table 93. Expression Therapeutics LLC Corporation Information
Table 94. Expression Therapeutics LLC Description and Business Overview
Table 95. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Expression Therapeutics LLC Hemophilia A Drug Product
Table 97. Expression Therapeutics LLC Recent Developments/Updates
Table 98. Green Cross Corp Corporation Information
Table 99. Green Cross Corp Description and Business Overview
Table 100. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Green Cross Corp Hemophilia A Drug Product
Table 102. Green Cross Corp Recent Developments/Updates
Table 103. Idogen AB Corporation Information
Table 104. Idogen AB Description and Business Overview
Table 105. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Idogen AB Hemophilia A Drug Product
Table 107. Idogen AB Recent Developments/Updates
Table 108. Immusoft Corp Corporation Information
Table 109. Immusoft Corp Description and Business Overview
Table 110. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Immusoft Corp Hemophilia A Drug Product
Table 112. Immusoft Corp Recent Developments/Updates
Table 113. LFB SA Corporation Information
Table 114. LFB SA Description and Business Overview
Table 115. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. LFB SA Hemophilia A Drug Product
Table 117. LFB SA Recent Developments/Updates
Table 118. mAbxience SA Corporation Information
Table 119. mAbxience SA Description and Business Overview
Table 120. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. mAbxience SA Hemophilia A Drug Product
Table 122. mAbxience SA Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Hemophilia A Drug Distributors List
Table 126. Hemophilia A Drug Customers List
Table 127. Hemophilia A Drug Market Trends
Table 128. Hemophilia A Drug Growth Drivers
Table 129. Hemophilia A Drug Market Restraints
Table 130. Global Hemophilia A Drug Sales Forecast by Type (2022-2027) & (K Pcs)
Table 131. Global Hemophilia A Drug Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Hemophilia A Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Hemophilia A Drug Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Hemophilia A Drug Sales Forecast by Application (2022-2027) & (K Pcs)
Table 135. Global Hemophilia A Drug Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Hemophilia A Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Hemophilia A Drug Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Hemophilia A Drug Sales Forecast by Region (2022-2027) & (K Pcs)
Table 139. Global Hemophilia A Drug Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Hemophilia A Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Hemophilia A Drug Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hemophilia A Drug
Figure 2. Global Hemophilia A Drug Market Share by Type in 2020 & 2027
Figure 3. ATXF-8117 Product Picture
Figure 4. BAY-1093884 Product Picture
Figure 5. BIVV-001 Product Picture
Figure 6. BS-027125 Product Picture
Figure 7. Concizumab Product Picture
Figure 8. CSL-689 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Hemophilia A Drug Market Share by Application in 2020 & 2027
Figure 11. Clinic
Figure 12. Hospital
Figure 13. ASCs
Figure 14. Global Hemophilia A Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hemophilia A Drug Market Size 2016-2027 (US$ Million)
Figure 16. Global Hemophilia A Drug Sales 2016-2027 (K Pcs)
Figure 17. Global Hemophilia A Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Hemophilia A Drug Sales Share by Manufacturers in 2020
Figure 19. Global Hemophilia A Drug Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Hemophilia A Drug Players: Market Share by Revenue in 2020
Figure 21. Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Hemophilia A Drug Sales Market Share by Region (2016-2021)
Figure 23. Global Hemophilia A Drug Sales Market Share by Region in 2020
Figure 24. Global Hemophilia A Drug Revenue Market Share by Region (2016-2021)
Figure 25. Global Hemophilia A Drug Revenue Market Share by Region in 2020
Figure 26. U.S. Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Hemophilia A Drug by Type (2016-2021)
Figure 51. Sales Market Share of Hemophilia A Drug by Application (2016-2021)
Figure 52. Sales Market Share of Hemophilia A Drug by Application in 2020
Figure 53. Revenue Share of Hemophilia A Drug by Application (2016-2021)
Figure 54. Revenue Share of Hemophilia A Drug by Application in 2020
Figure 55. Manufacturing Cost Structure of Hemophilia A Drug
Figure 56. Manufacturing Process Analysis of Hemophilia A Drug
Figure 57. Hemophilia A Drug Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

LIST OF FIGURE